Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cobalt plaque therapy of posterior uveal melanomas

Journal Article · · Ophthalmology (Rochester, Minn.); (United States)
One hundred patients with choroidal melanomas who were treated by the authors with cobalt plaque radiotherapy were analyzed with regard to tumor regression, visual results, complications, and mortality rate. The follow-up period at the time of this writing ranged from one to five years. These preliminary observations indicate that cobalt plaque radiotherapy induces tumor regression in 96% of cases, preserves useful vision in many cases and has fewer complications during the one- to five-year follow-up period than previously believed.
Research Organization:
Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia
OSTI ID:
5992513
Journal Information:
Ophthalmology (Rochester, Minn.); (United States), Journal Name: Ophthalmology (Rochester, Minn.); (United States) Vol. 89:10; ISSN OPHTD
Country of Publication:
United States
Language:
English